|
This report is submitted beyond 30-calendar days from allergan¿s receipt due to the exemption transition period.Information contained in this report was previously submitted through psr on 22/apr/2019.A review of the device history record has been completed.No deviations or non-conformance's noted.Device evaluation: analysis of the returned device identified weight of the device within specification, fold creases, and a deformation.There was a cloudy color observed in the gel after the autoclave cycle.Based on the device analysis, the final assessment is no issues found related with the manufacturing process.The event of capsular contracture is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.The reason for reoperation is capsular contracture, baker grade iii.This is a known potential adverse event addressed in the product labeling.
|